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Summary.  19 
Altered physiological states require neuronal adaptation. In late-pregnancy and 20 
lactation, a sub-population of the mouse hypothalamic tuberoinfundibular dopaminergic 21 
(TIDA) neurons alter their behaviour to synthesize and release met-enkephalin rather than 22 
dopamine. These neurons normally release dopamine to inhibit prolactin secretion, and are 23 
activated by prolactin in a short-loop feedback manner. In lactation, dopamine synthesis is 24 
suppressed in an opioid-dependent (naloxone reversible) manner, meaning that prolactin 25 
secretion is disinhibited. Conditional deletion of the prolactin receptor in neurons reveals that 26 
this change in phenotype appears to be driven by prolactin itself, apparently through an 27 
alteration in intracellular signalling downstream of the prolactin receptor that favours 28 
enkephalin production instead of dopamine. Thus, prolactin effectively facilitates its own 29 
secretion, which is essential for lactation and maternal behaviour. These studies provide 30 
evidence of a physiologically important, reversible alteration in the behaviour of a specific 31 
population of hypothalamic neurons in the adult brain. 32 
 33 
Introduction.  34 
The anterior pituitary hormone, prolactin, mediates a wide range of physiological 35 
functions in addition to its archetypal lactotropic actions on the mammary gland (Bernichtein 36 
et al., 2010; Grattan, 2015; Grattan and Kokay, 2008). Within the brain, many of prolactin's 37 
actions facilitate maternal adaptation to pregnancy and behaviours conducive to the successful 38 
rearing of young (Brunton et al., 2008; Grattan and Kokay, 2008; Larsen and Grattan, 2012). 39 
In contrast to other pituitary hormones, endogenous prolactin secretion is high and 40 
predominately regulated by inhibitory tone from the hypothalamus, with disinhibition being a 41 
predominant mode of facilitating secretion. The anterior pituitary lactotrophs spontaneously 42 
release prolactin, which is tonically inhibited by dopamine secreted within the median 43 
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eminence from the terminals of tuberoinfundibular dopaminergic (TIDA) neurons. In males 44 
and non-pregnant females low circulating levels of prolactin are maintained by a "short-loop" 45 
negative feedback in which prolactin directly interacts with the TIDA neurons to increase 46 
their firing rate and thus dopamine output (Brown et al., 2016; Brown et al., 2012; Freeman et 47 
al., 2000; Grattan et al., 2008; Lyons et al., 2012; Romano et al., 2013). 48 
During late-pregnancy and lactation, circulating prolactin levels rise to support 49 
lactation and enable maternal behavioural adaptations (Arbogast and Voogt, 1996; Brisken et 50 
al., 1999; Grattan et al., 2008). For this to occur, the dopamine-mediated inhibitory tone upon 51 
the lactotrophs must be alleviated, despite the on-going presence of elevated prolactin levels 52 
(and during late pregnancy, placental lactogen) in the circulation. A number of studies have 53 
suggested that the TIDA neurons become "refractory" to prolactin-mediated negative 54 
feedback during this time. For example, central administration of prolactin to non-pregnant 55 
female rats increases activity of tyrosine hydroxylase (TH), the rate limiting step in 56 
dopamine synthesis, in the median eminence in non-pregnant rats, but has no effect 57 
during lactation (Arbogast and Voogt, 1996; Demarest et al., 1983). Similarly, despite 58 
elevated prolactin levels during lactation, the rat arcuate nucleus shows reduced levels of both 59 
TH mRNA and TH protein, with an associated reduction in dopamine turnover and secretion 60 
at the median eminence (Andrews, 2005; Szabo et al., 2011). This down-regulation of 61 
prolactin-induced dopamine synthesis and secretion during lactation does not arise from a 62 
reduction in prolactin receptor expression, with in situ hybridization revealing similar levels 63 
of prolactin receptor mRNA in the arcuate nucleus of non-pregnant and lactating rats and 64 
mice (Augustine et al., 2003; Brown et al., 2011; Kokay and Grattan, 2005). Most strikingly, 65 
we have shown that prolactin-induced electrophysiological responses in TIDA neurons are 66 
unaltered between non-pregnant and lactating mice although they now fail to synthesize and 67 
release dopamine (Romano et al., 2013).  68 
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Intriguing observations made almost 25 years ago indicated that the opioid peptide 69 
enkephalin was expressed in the TIDA neurons during lactation (Ciofi et al., 1993; 70 
Merchenthaler, 1994). Since dopamine production is lost during this state, TIDA neurons may 71 
switch their phenotype from dopaminergic to enkephalinergic during lactation. Given that 72 
these neurons remain electrophysiologically-responsive to prolactin during lactation (Romano 73 
et al., 2013), it seems likely that enkephalin rather than dopamine may be the neurochemical 74 
output from these neurons at this time. Such a switch in output would be expected to have 75 
significant physiological consequences for the regulation of prolactin secretion during 76 
lactation.  77 
The aim of this study was to test the hypothesis that prolactin feedback is responsible 78 
for the neurotransmitter switch in the TIDA neurons during late-pregnancy and lactation. We 79 
also investigated the hypothesis that the transition from a dopaminergic to enkephalinergic 80 
phenotype involves an alteration in signal transduction pathways downstream of the prolactin 81 
receptor. Finally, we have investigated if prolactin stimulates enkephalin release from the 82 
median eminence in the lactating mouse, and the consequences of such action in terms of 83 
pituitary function. Together, the data suggest a profound change in the hypothalamic 84 
regulation of prolactin secretion during lactation, promoting a state of hyperprolactinemia. 85 
Essentially during this time, the short-loop negative feedback regulation of prolactin secretion 86 
switches to a condition where elevated prolactin facilitates its further secretion. Similar 87 
mechanisms may occur in other neuronal populations that undergo plasticity over lifespan in 88 
adults.  89 
 90 
Results 91 
Met-enkephalin expression in the arcuate nucleus of the mouse is increased 92 
during lactation. There was no change in the number of TH-immunoreactive cells within the 93 
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arcuate nucleus during late-pregnancy and lactation (Figure 1, A-D). The level of Th mRNA 94 
expression in the arcuate nucleus was however markedly affected (F (2,22) = 5.72, p < 0.01, 95 
one-way ANOVA) such that it was significantly reduced during both late-pregnancy and 96 
lactation compared to diestrus controls (p < 0.05, Tukey's multiple comparison test test, 97 
Figure 1E). There was also a change in proenkephalin (Penk) mRNA expression during this 98 
time (F (2,22) = 18.25, p < 0.0001, one-way ANOVA) with its level increased during both 99 
late-pregnancy and lactation compared to diestrus animals (p < 0.0001 and p < 0.05, 100 
respectively, Tukey’s multiple comparison test, Figure 1J). The number of met-enkephalin 101 
immunoreactivity cells within the arcuate nucleus also increased during this time (F (2,11) = 102 
17.57, p < 0.001, one-way ANOVA) being significantly greater during late-pregnancy (p < 103 
0.001) and lactation (p < 0.001) compared to diestrus controls (Tukey’s multiple comparison 104 
test, Figure 1 F- I). The lactation-associated rise in met-enkephalin expressing cell number 105 
was specific to the arcuate nucleus, with no significant change in met-enkephalin expression 106 
in the paraventricular nucleus and a significant decline in the dorsomedial hypothalamus 107 
(Figure S1). 108 
During lactation the majority of met-enkephalin expressing cells in the arcuate 109 
nucleus are also immunoreactive for tyrosine hydroxylase. In the dorsomedial arcuate 110 
nucleus, the primary location of the TIDA neurons (Freeman et al., 2000), the number of cells 111 
that were dual-labelled for TH and met-enkephalin increased markedly during lactation 112 
(Figure 1K-P). In diestrus animals, less than 10% of the met-enkephalin immunoreactive cells 113 
also expressed TH, whereas during lactation this number had risen to about 80% (p < 0.005, 114 
Student’s t-test, Figure 1Q). It should be noted, however, that even during lactation, while the 115 
number of dual-labelled cells was significantly increased (p < 0.005, Student’s t-test) they 116 
constituted only approximately a third of all TH-positive neurons present in this region (34.8 117 
± 3.8%) (Figure 1R). 118 
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The lactation-induced increase in met-enkephalin and Penk mRNA expression in 119 
TIDA neurons is mediated by prolactin. Alteration of prolactin levels significantly affected 120 
the number of met-enkephalin cells in the dorsomedial arcuate nucleus (F (3,16) = 23.84, p < 121 
0.0001, one-way ANOVA, Figure 2A-E). As expected, lactation increased the number of met-122 
enkephalin immunoreactive cells compared to diestrus (p < 0.0005, Tukey’s multiple 123 
comparison test, Figure 2; panels A, B and E). Suppressing prolactin levels in lactating mice 124 
with bromocriptine from 355.6 ± 62.7 ng/ml to 45.3 ± 9.1 ng/ml (compared to 18.2 ± 6.0 125 
ng/ml during diestrus), significantly reduced the number of these cells (p < 0.01, Tukey’s 126 
multiple comparison test) to approximately half that seen in untreated lactating animals 127 
(Figure 2E, 22.2 ± 2.1 cells per section in lactating animals falling to 10.9 ± 2.6 cells per 128 
section following treatment with bromocriptine). Furthermore, maintaining serum prolactin 129 
levels in bromocriptine-treated lactating mice with ovine prolactin (245.8 ± 69.1 ng/ml) 130 
prevented this decrease in number of met-enkephalin-expressing cells such that it was similar 131 
to that seen during lactation (30.4 ± 2.1 cells per section; Figure 2; panels D and E). In situ 132 
hybridization revealed that the number of cells in the arcuate nucleus expressing Penk mRNA 133 
during lactation increased more than 10-fold compared to diestrus animals (1.6 ± 0.5 to 20.2 ± 134 
2.0 cells per section) (Figure 2F, G and H). Similarly, the number of cells expressing Penk 135 
mRNA, which was low in lactating animals 24 h after pup withdrawal, was significantly 136 
increased when  the circulating concentration of prolactin was increased to greater than 100 137 
ng/ml by osmotic pump infusion of exogenous prolactin (2.7 ± 1.2 to 11.8 ± 4.2 cells per 138 
section) (Figure 2 I, J and K).  139 
 140 
The lactation-induced increase in met-enkephalin and Penk mRNA expression in 141 
the TIDA neurons is dependent on a neuronal prolactin receptor. The observations above 142 
suggest that prolactin acts on TIDA neurons during late-pregnancy or lactation to promote 143 
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met-enkephalin expression. This concept was confirmed by data obtained from 144 
PRLRlox/lox/CamK-Cre mice, which lack prolactin receptors in forebrain neurons, including 145 
TIDA neurons (Brown et al., 2016). Despite being hyperprolactinemic, due to the lack of 146 
prolactin feedback on TIDA neurons, these animals could become pregnant but often failed to 147 
nurse their pups (Brown et al., 2016). Hence, all investigations were conducted on day 18 of 148 
pregnancy. Both reproductive (F (1,17) = 9.03, p < 0.01, two-way ANOVA) and genetic (F 149 
(1,17) = 12.84, p < 0.005, two-way ANOVA) status significantly influenced the number of 150 
met-enkephalin positive cells in the arcuate nucleus, with a significant interaction between the 151 
two factors (F (1,17) = 13.9, p < 0.005, two-way ANOVA, Figure 3A - E). In contrast to age-152 
matched PRLRlox/lox Cre-negative controls, the prolactin receptor-deleted animals showed no 153 
increase in arcuate nucleus met-enkephalin immunoreactivity in late-pregnancy, with the 154 
number of met-enkephalin immunoreactive cells remaining unchanged from those in the non-155 
pregnant state, (3.9 ± 0.8 and 4.6 ± 2.1 cells per section, respectively; Figure 3C, D and E). As 156 
can be seen in Figure 3 F-J deletion of the neuronal prolactin receptor had an essentially 157 
identical effect on Penk mRNA expression in the arcuate nucleus with the rise in the number 158 
of Penk mRNA positive cells during late pregnancy being abolished in animals lacking the 159 
neuronal prolactin receptor (F (1, 19) = 109.1, p < 0.0001, two-way ANOVA, Figure 3J). 160 
 161 
Prolactin receptor-mediated signaling in the TIDA neurons is altered during 162 
lactation. If, as our data suggest, prolactin stimulation of TIDA neurons can drive met-163 
enkephalin expression during late-pregnancy and lactation, but drives dopamine synthesis and 164 
secretion at other times, this may indicate a pregnancy-induced change to the signal-165 
transduction pathways mediating prolactin action in the TIDA neurons. Prolactin receptor 166 
stimulation activates both the signal-transducer and activator of transcription 5 (STAT5) and 167 
extracellular signal-regulated 1/2 (ERK1/2) pathways. Immunohistochemistry revealed that 168 
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reproductive status has a significant effect on the number of TH-immunoreactive cells 169 
expressing activated (tyrosine phosphorylated) STAT5 (pSTAT5) (F (2,15) = 98.82, p < 170 
0.0001, two-way ANOVA) and that this was significantly influenced by experimental 171 
manipulation of prolactin levels (F (2,15) = 12.47, p < 0.001, two-way ANOVA). During 172 
diestrus, slightly less than half (46.8 ± 7.9 %) of the TH immunoreactive cells in the 173 
dorsomedial arcuate displayed nuclear pSTAT5 labelling (Figure 4A and G). As expected, due 174 
to the elevated circulating prolactin in lactating mice, this number significantly increased to 175 
81.6 ± 4.0% (p < 0.01, Tukey’s multiple comparisons test, Figure 4D and G). Suppression of 176 
prolactin secretion with bromocriptine essentially abolished pSTAT5 immunoreactivity in 177 
both diestrus and lactating animals (Figure 4B, E and G). Acute administration of exogenous 178 
prolactin to bromocriptine-treated animals resulted in a significant, and similar, increase in the 179 
number of TH-pSTAT5 dual-labelled cells in both diestrus and lactating animals (p < 0.0001, 180 
Tukey’s multiple comparisons test in both cases) compared to that seen following 181 
bromocriptine treatment (Figure 4C, F and G). The data in Figure 4 also shows that 182 
reproductive status alters the number of TH-immunoreactive cells expressing phosphorylated 183 
ERK1/2 (pERK1/2) (F (2,19) = 13.45, p < 0.0003, two-way ANOVA) and that this was 184 
significantly influenced by experimental manipulation of prolactin levels (F (2,19) = 26.29, p 185 
< 0.0001, two-way ANOVA). During diestrus, a lower percentage of TH-immunoreactive 186 
cells were dual-labelled for pERK1/2 compared to those expressing pSTAT5 (compare Figure 187 
4G with 4N). The number of pERK1/2 stained TH-cells increased markedly in lactation, 188 
rising approximately four-fold from 4.8 ± 0.5% in diestrus to 21.6 ± 4.5% in lactation (p < 189 
0.01, Tukey’s multiple comparisons test; Figure  4H, K and N). Bromocriptine treatment did 190 
not affect pERK1/2 expression in diestrus animals but abolished the lactation-associated rise 191 
(Figure 4I, L and N). While acute treatment with exogenous prolactin to bromocriptine-treated 192 
animals stimulated an almost 10-fold increase in the number of TH positive cells also 193 
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expressing pERK1/2 in diestrus mice (p < 0.001, Tukey’s multiple comparisons test, Figure 4J 194 
and N), it was without a significant effect on lactating animals (Figure 4M and N). The effect 195 
of acute prolactin treatment on bromocriptine-treated animals was also investigated using 196 
Western blot analysis of arcuate nucleus micro-punch samples. In agreement with the 197 
immunohistochemical data described above Western blot analysis confirmed that acute 198 
prolactin treatment (20 min) increased pSTAT5 levels in both diestrus and lactating mice but 199 
the pERK1 and pERK2 responses were lost in the latter (Figure S2). 200 
 201 
Prolactin stimulates the release of met-enkephalin from the median eminence of 202 
the lactating mouse which may reduce the activity of tyrosine hydroxylase. Met-203 
enkephalin expression in TIDA neurons during late-pregnancy and lactation may lead to its 204 
release at the median eminence. To examine this possibility, brain slices at the level of the 205 
arcuate nucleus from lactating mice were exposed to saline or prolactin for 30 min and then 206 
fixed and dual-stained for met-enkephalin and TH. Under basal conditions, strong met-207 
enkephalin immunoreactivity was closely associated with the TH-expressing external zone of 208 
the median eminence (Figure 5A, left panels). After prolactin application, the intensity of the 209 
TH staining remained unchanged, whereas met-enkephalin immunoreactivity was 210 
significantly reduced compared to that seen in slices treated with saline alone (Figure 5A and 211 
B). Since these data suggest that prolactin may stimulate met-enkephalin release from nerve 212 
terminals in the median eminence of lactating mice we investigated two possible 213 
physiological targets for this opioid peptide. Firstly, the TIDA neurons themselves, and 214 
secondly, the anterior pituitary lactotrophs. In the former experiments, pregnant mice were 215 
treated with the opioid receptor antagonist, naloxone, from late gestation to day 10 of 216 
lactation. Western blot analysis of hypothalamic tissue from these animals showed a 217 
significant increase in the level of activated TH (as indicated its phosphorylation on serine-40) 218 
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compared to that seen in lactating animals treated with saline only (Figure 5C, p < 0.05, 219 
Student’s t-test). These data are consistent with a tonic opioid-mediated inhibition of TH 220 
phosphorylation in the TIDA neurons during lactation, which would effectively reduce the 221 
activity of this enzyme and thus suppress the production of dopamine.  222 
 223 
Met-enkephalin increases Ca2+ signaling and prolactin secretion from pituitary 224 
lactotrophs of lactating mice.  To determine the effect of met-enkephalin on the lactotrophs, 225 
pituitary slices from prolactin-DsRed animals (He et al., 2011; Hodson et al., 2012)were 226 
loaded with the Ca2+ indicator Fura-2, and the Ca2+-responses measured. In approximately 227 
one third of the cells, a 15-min treatment with met-enkephalin (500 nM) induced a strong 228 
increase in the Ca2+-spiking activity of the lactotroph population (n = 327/957 responsive 229 
lactotrophs in 7 slices from 3 animals) (Figure 6 A-C). Analysis of the frequency domain 230 
using Short-Time Fourier Transform confirmed the presence of increased power at higher 231 
frequency ranges during the application of met-enkephalin, indicating a statistically 232 
significant effect of treatment on lactotroph Ca2+-spiking activity (Figure 6 D-E). To 233 
determine whether this corresponded to an increase in lactotroph output, hemi-pituitary 234 
explants from lactating animals were incubated for 10 min with met-enkephalin (500 nM) 235 
followed by measurement of prolactin concentrations in the medium by ELISA. Met-236 
enkephalin induced a moderate but significant increase in prolactin secretion compared to 237 
controls (Figure 6F, p < 0.05, n = 4-6 pituitaries). 238 
 239 
Discussion  240 
Physiological hyperprolactinemia is essential for successful lactation, since it 241 
establishes milk production and facilitates adaptation of maternal physiology and 242 
behavior (Grattan et al. 2008, Grattan and Le Tissier 2015). Elevation of circulating 243 
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prolactin concentration is achieved, at least in part, by a relaxation of the negative-244 
feedback pathway by which prolactin suppresses its own secretion through promoting 245 
dopamine release from the TIDA neurons. We have shown previously that while the 246 
TIDA neurons reduce dopamine synthesis and release during lactation, they remain 247 
electrophysiologically responsive to prolactin (Romano et al., 2013). The 248 
physiological significance of this persistent prolactin response in the absence of a 249 
dopaminergic output has been unknown. We report here that during late-pregnancy 250 
and lactation, a sub-population of TIDA neurons undergoes a prolactin-dependent 251 
transition from a dopaminergic to enkephalinergic phenotype. Prolactin-induced 252 
stimulation of met-enkephalin release from the TIDA neurons during lactation may 253 
promote further prolactin secretion from the pituitary, through either suppression of 254 
dopamine synthesis and release, or a direct stimulatory action on the lactotrophs. 255 
Thus, a sub-population of the TIDA neurons appear to undergo a phenotypic switch 256 
during late-pregnancy and lactation, converting a dopaminergic short-loop negative 257 
feedback system into one using met-enkephalin to induce a positive stimulus for 258 
prolactin release. Such neurotransmitter switching is becoming increasingly 259 
recognized as a form of neuronal plasticity (Spitzer, 2017). Our proposed model of 260 
TIDA neuron plasticity during late-pregnancy and lactation is summarized 261 
diagrammatically in Figure 7.  262 
Lactation was associated with a decrease in Th mRNA and an increase in 263 
Penk mRNA within the arcuate nucleus. The observation that these changes were 264 
already present in late-pregnancy suggests they result from hormonal, as well as 265 
suckling-induced neuronal signaling to the TIDA neurons (Berghorn et al., 2001; 266 
Szabo et al., 2011; Wang et al., 1993). The absence of a corresponding reduction in 267 
the level of TH protein indicates the complex nature of TH regulation (Kumer and 268 
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Vrana, 1996) but is consistent with previous findings showing that reduced dopamine 269 
synthesis in this region results from lower levels of the activated TH  270 
(serine-40 phosphorylated), rather than total enzyme (Romano et al., 2013). Dual-271 
labelling for TH and met-enkephalin immunoreactivity indicated that approximately a 272 
third of the dopaminergic neurons, presumed to be TIDA neurons, also expressed 273 
met-enkephalin during lactation. While this is a marked rise from the situation in 274 
diestrus animals, it contrasts with findings in the lactating rat where almost all TIDA 275 
neurons expressed enkephalin (Merchenthaler, 1994; Merchenthaler et al., 1995). It 276 
should be noted however that, unlike the data reported here, the antibody used in 277 
these earlier studies does not distinguish between met- and leu-enkephalin. While 278 
the actual percentage of dual-labelled cells may be influenced by species or 279 
methodological differences, our current data is consistent with growing recognition 280 
that the TIDA neurons may not represent a homogeneous population. Arcuate 281 
dopamine neurons have been found, for example, to exist in distinct groups in terms 282 
of their electrophysiological characteristics (Liang and Pan, 2011; Romano et al., 283 
2013; Zhang and van den Pol, 2015), expression of potential co-transmitters (Brown 284 
et al., 2016) and catecholamine synthesizing enzymes and transporters (Battaglia et 285 
al., 1995; Ugrumov, 2009). Most strikingly, recent studies using single cell genetic 286 
profiling have identified up to six subtypes of dopaminergic neurons in this region 287 
(Campbell et al., 2017; Romanov et al., 2017). It is currently unknown if the met-288 
enkephalin-expressing TIDA neurons are coincident with one of these identified sub-289 
populations, but the observation that essentially all TH-immunoreactive nerve 290 
terminals in the mouse median eminence also stained for enkephalin during lactation 291 
(Ciofi et al., 1993) suggests they may preferentially target the median eminence and 292 
thereby represent true neuroendocrine neurons.  293 
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The induction of met-enkephalin in the TIDA neurons was driven by prolactin, and 294 
was lost following pharmacological suppression of prolactin during lactation, or in the 295 
absence of prolactin receptors in the brain. These observations are supported by previous 296 
findings in the rat that indicated that prolactin can induce enkephalin expression in TIDA 297 
neurons during lactation (Merchenthaler et al., 1995; Nahi and Arbogast, 2003). The fact that 298 
the changes were initiated during pregnancy suggests that placental lactogen is likely to be the 299 
major factor acting through the prolactin receptor to mediate this effect. It should be noted 300 
that while the D2 agonist bromocriptine was employed in these studies to suppress prolactin 301 
release from the pituitary it may also target other D2 receptors including dopaminergic 302 
autoreceptors expressed on the TIDA neurons which have been reported to provide an 303 
ultrafast negative feedback (Stagkourakis et al., 2016). The profile of Penk mRNA 304 
expression, determined by in situ hybridization, paralleled the above immunohistological 305 
observations, with the lactation-associated rise in number of Penk mRNA positive cells within 306 
the arcuate nucleus being reversed by prolactin depletion (following pup-withdrawal) and 307 
partially restored by prolactin replacement. Similary, depletion of neuronal prolactin receptors 308 
also prevented a lactational rise in the number of Penk mRNA expressing cells. 309 
The ability of prolactin to switch from driving a dopaminergic to an enkephalinergic 310 
output from the TIDA neurons during late-pregnancy and lactation may result from a 311 
modification to the intracellular signaling profile activated by its receptor. The physiological 312 
trigger for such a change is likely to arise from the dramatic pregnancy-specific alteration in 313 
the pattern of prolactin receptor activation occurring at this time, with high levels of placental 314 
lactogen providing a prolonged, chronic stimulus as distinct from the short-term, phasic 315 
patterns of prolactin secretion seen in early pregnancy. While prolactin receptors are coupled 316 
to multiple intracellular signals, we focused on the two major pathways mediated by pSTAT5 317 
and pERK1/2, respectively (Freeman et al., 2000). As expected, the elevation of endogenous 318 
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prolactin during lactation significantly increased the percentage of dopaminergic (TH-319 
expressing) cells also labelled with pSTAT5 or pERK1/2 compared to the levels seen in 320 
diestrus animals when prolactin is low. Interestingly, if endogenous prolactin levels were first 321 
suppressed with bromocriptine, diestrus and lactating animals exhibited a similar pSTAT5 322 
responsiveness to the injection of exogenous prolactin, but the pERK1/2 signal was lost in the 323 
latter group. This conclusion was supported by parallel Western blot analysis which also 324 
showed preservation of the prolactin-induced pSTAT5 response but loss of the pERK 325 
signalling during lactation. This suggests that while prolactin receptor coupling to the 326 
pSTAT5 pathway is unchanged between the two physiological states, its ability to signal via 327 
pERK1/2 has been markedly down-regulated in the lactating mice. It should be noted that 328 
while pSTAT5 is primarily a transcription factor, pERK is a multifunction protein kinase with 329 
both nuclear and cytoplasmic targets. While the role of a diminished pERK1/2 response in 330 
prolactin-mediated met-enkephalin expression is unknown, it is consistent with a reduction in 331 
the phosphorylation of TH and thus a fall in the dopamine-synthesizing capacity of these 332 
neurons. 333 
The proposal that TIDA neurons release enkephalin rather than dopamine during 334 
lactation is supported by evidence that increased opioid signaling may underlie lactational 335 
hyperprolactinemia (Arita and Kimura, 1988; Chihara et al., 1978; Meltzer et al., 1978; Rivier 336 
et al., 1977). Most notably immunoneutralization of endogenous opioids or the administration 337 
of naloxone (or mu- or kappa-selective opioid receptor antagonists) suppresses both the 338 
antepartum prolactin surge and suckling-induced prolactin secretion in rats (Andrews and 339 
Grattan, 2002; Arbogast and Voogt, 1998; Callahan et al., 2000). Furthermore, both mu and 340 
kappa opioid receptor mRNA is expressed in the medial basal hypothalamus (Tavakoli-341 
Nezhad and Arbogast, 2010) and lactation is associated with increased enkephalin-342 
immunoreactivity in the median eminence (Ciofi et al., 1993; Merchenthaler, 1994). While 343 
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the physiological targets of secreted opioid peptide have yet to be determined, close 344 
appositions between met-enkephalin fibres and dopaminergic neurons in the median eminence 345 
and arcuate nucleus suggest a possible opioid action on the TIDA neurons (Magoul et al., 346 
1993; Magoul et al., 1994; Mansour et al., 1993; Zhang and van den Pol, 2015), a possibility 347 
supported by electrophysiological data that opioid receptor agonists inhibit TIDA neuron 348 
activity (Zhang and van den Pol, 2015). Similarly, in vivo and in vitro studies have shown that 349 
enkephalin inhibits dopamine turnover in the median eminence (Arita and Kimura, 1988; 350 
Ferland et al., 1977) an observation consistent with the data presented here that naloxone 351 
increases the serine-40 phosphorylation, and thus activity, of TH in the arcuate nucleus of the 352 
lactating mouse. These results suggest that during late-pregnancy and lactation, prolactin- or 353 
placental lactogen-induced met-enkephalin released from TIDA neurons may exert autocrine 354 
signaling to suppress dopamine output and thus disinhibit the lactotrophs allowing increased 355 
prolactin release from the pituitary.  356 
The data presented in Figure 6 suggests that prolactin may stimulate met-enkephalin 357 
release from the median eminence from where it may potentially access and target the 358 
pituitary lactotrophs. While this interpretation of these immunohistochemical data is 359 
consistent with our overall hypothesis, it is important to stress that this approach does not 360 
directly measure enkephalin release, and should therefore be interpreted conservatively. 361 
Further verification using a more direct quantitative approach will be required to confirm this. 362 
Such a proposal is however supported by the presence of opioid receptors on a subset of 363 
anterior pituitary cells in the rat (Carretero et al., 2004), and evidence that met-enkephalin 364 
either promotes prolactin secretion (Carretero et al., 1992) or overcomes its suppression by 365 
dopamine (Enjalbert et al., 1979). Our current data extends these observations by showing 366 
that met-enkephalin directly increases Ca2+-signaling in a sub-population of lactotrophs in the 367 
intact mouse pituitary gland, and that this response is concurrent with increased prolactin 368 
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secretion. Thus, it is possible that met-enkephalin released by the TIDA neurons during late-369 
pregnancy and lactation can directly enhance the secretory activity of the lactotrophs.  370 
Collectively, these data reveal a remarkable plasticity in TIDA neurons during late-371 
pregnancy and lactation. We propose a model whereby chronically elevated placental 372 
lactogen modifies prolactin receptor signalling leading to a reduction in ERK1/2-mediated 373 
phosphorylation of TH, and a concurrent activation of met-enkephalin expression. The 374 
consequent reduction of dopamine synthesis means that in response to continued stimulation 375 
by prolactin, these neurons alter their behaviour and secrete met-enkephalin instead of 376 
dopamine. The met-enkephalin acts via opioid autoreceptors on the TIDA neurons, further 377 
suppressing the activity of TH. It may also travel in the portal blood to the pituitary, where it 378 
promotes prolactin secretion from the lactotrophs. These changes facilitate suckling-induced 379 
prolactin secretion, by allowing it to be maintained unopposed by a negative feedback, and 380 
indeed potentially facilitated by positive feedback actions. This adaptive switch in TIDA 381 
neuron behaviour establishes a period of hyperprolactinemia that is only terminated by the 382 
weaning of the pups. 383 
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Figure Legends 404 
Figure 1. Met-enkephalin expression in tyrosine hydroxylase positive neurons within the 405 
arcuate nucleus is increased during lactation. Representative images of arcuate nucleus 406 
sections showing tyrosine hydroxylase (TH) (A-C) and met-enkephalin (F-H) 407 
immunoreactive cells in diestrus (A, F), late-pregnant (B, G) and lactating (C, H) mice. 408 
Quantification of the number of TH and met-enkephalin immunoreactive cells is shown in 409 
panels D and I, respectively and is presented as the mean ± SEM per section (data analyzed 410 
by one-way ANOVA followed by Tukey’s multiple comparison test, n = 4-5). Th and Penk 411 
mRNA expression in the arcuate nucleus is shown in panels E and J, respectively, with levels 412 
in late-pregnancy and lactation presented relative to those found during diestrus (data 413 
analyzed by one-way ANOVA followed by a Tukey’s multiple comparison test, n = 6-11). 414 
Panels K-M present representative confocal images of dorsomedial arcuate nucleus sections 415 
showing TH (green), met-enkephalin (red) immunoreactive cells and merged images of 416 
diestrus and lactating mice. Filled arrowheads indicate TH immunoreactive cell bodies co-417 
labelled with met-enkephalin and open arrowheads indicate either TH or met-enkephalin 418 
immunoreactive cell bodies which are not dual-labelled. Panel Q presents the percentage of 419 
met-enkephalin immunoreactive cells that were also stained for TH in the dorsomedial arcuate 420 
nucleus. Whereas panel R presents the percentage TH immunoreactive cells in the same 421 
region that were also stained for met-enkephalin. Data represent the mean ± SEM (n = 3-4 422 
mice) and statistical analysis was performed using an unpaired Student’s t-test. 3V = third 423 
ventricle, Scale bars: panels A-C and F-H = 100 μm, and panels K-P = 30 μm. * p < 0.05, *** 424 
p < 0.005, **** p < 0.001 and ***** p < 0.0001. 425 
 426 
 427 
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Figure 2. The lactation-induced increase in met-enkephalin and Penk mRNA expression 428 
in TIDA neurons is mediated by prolactin. Panels A-D present representative images of 429 
met-enkephalin immunoreactivity in the dorsomedial arcuate nucleus of diestrus, lactating 430 
and bromocriptine-treated lactating mice with or without ovine prolactin replacement. 431 
Quantitation of the number of met-enkephalin immunoreactive cells per section under each 432 
condition is presented in panel E. Data represent the mean ± SEM and statistical analysis was 433 
conducted using one-way ANOVA followed by a Tukey’s multiple comparison test (n = 5-8).  434 
Panels F-H compare Penk mRNA expression between diestrus and lactating mice. 435 
Quantitation of the number of Penk mRNA positive cells per section under each condition is 436 
presented in panel H. Data represent the mean ± SEM and statistical analysis was performed 437 
using an unpaired Student’s t-test (n = 4-6 mice). Panels I-K show that exogenous prolactin 438 
increases the number of cells expressing Penk mRNA in lactating animals that have 439 
undergone pup-withdrawal (high prolactin defined as >100 ng/ml). Quantitation of the 440 
number of Penk mRNA positive cells per section under each condition is presented in panel 441 
K. Data represent the mean ± SEM and statistical analysis was conducted using one-way 442 
ANOVA followed by a Tukey’s multiple comparison test (n = 3-7). Br = bromocriptine, Prl = 443 
ovine prolactin, 3V = third ventricle. Scale bars: 50 μm. * p < 0.05, ** p < 0.01, **** p < 444 
0.0005 and ***** p < 0.0001. 445 
 446 
Figure 3. The lactation-induced increase in met-enkephalin and Penk mRNA expression 447 
in the TIDA neurons is dependent on a neuronal prolactin receptor. Representative 448 
images of met-enkephalin immunoreactivity (A-D) and Penk mRNA expression (F-I) in the 449 
arcuate nucleus of diestrus and late-pregnant PRLRlox/lox and PRLRlox/lox/CamK-Cre mice.  450 
Quantitation of the number of met-enkephalin immunoreactive and Penk expressing cells per 451 
section under each of the above conditions is shown in panel E and J respectively. Data 452 
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represent the mean ± SEM and statistical analysis was performed using two-way ANOVA 453 
followed by a Tukey's multiple comparison test, n = 5-6). Grey columns = diestrus, pink 454 
columns = lactating, 3V = third ventricle. Scale bars: 75 μm. **** p < 0.0005 and ***** p < 455 
0.0001. 456 
 457 
Figure 4. Prolactin receptor-mediated signaling in the TIDA neurons is altered during 458 
lactation. Panels A-F provide representative images of dorsomedial arcuate nucleus showing 459 
TH (brown cytoplasmic staining) and pSTAT5 (black nuclear staining) immunoreactivity in 460 
diestrus (A-C) and lactating (D-F) mice. Some groups received bromocriptine pre-treatment 461 
with (C and F), or without (B and E), ovine prolactin. Panels i) and ii) present higher 462 
magnification images of the boxed areas in B and C showing single-labelled TH cells (white 463 
arrowheads) and dual-labelled TH/pSTAT5 cells (black arrowhead). The percentage of TH 464 
immunoreactive cells dual-labelled with pSTAT5 under each of the six experimental 465 
conditions is presented in panel G. Panels H-M provide representative epifluorescent images 466 
of dorsomedial arcuate nucleus showing TH (green) and pERK1/2 (red) immunoreactivity in 467 
diestrus (H-J) and lactating (K-M) mice. As above, some groups received bromocriptine 468 
treatment followed by acute (20 min) prolactin or saline. The percentage of TH 469 
immunoreactive cells dual-labelled with pERK1/2 under each of the six conditions is 470 
presented in panel N. All data represent the mean ± SEM and statistical analysis was 471 
performed using two-way ANOVA followed by Tukey's multiple comparison test (n = 3-6). 472 
Open columns = diestrus, shaded columns = lactating, 3V = third ventricle, Br = 473 
bromocriptine, Prl = ovine prolactin, scale bars = 50 μm. In panel G ** indicated p < 0.01 and 474 
in panel N ** p < 0.01 compared diestrus controls and *** p < 0.001 compared to 475 
bromocriptine-treated diestrus animals. 476 
 477 
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Figure 5. Prolactin stimulates the release of met-enkephalin from the median eminence 478 
of the lactating mouse which may reduce the activity of tyrosine hydroxylase. 479 
Representative images of the median eminence from lactating mice, showing prolactin-480 
induced secretion of met-enkephalin (panel A). The intensity of TH immunoreactivity (red) 481 
was not affected by a 30-min incubation with prolactin (upper images) whereas met-482 
enkephalin immunoreactivity (green) was reduced (lower images). B. Quantification of the 483 
met-enkephalin immunoreactivity in the median eminence (normalized for TH 484 
immunoreactivity) with or without prolactin (PRL) stimulation. Data represent the mean ± 485 
SEM (*p < 0.05, unpaired Student’s t-test, n = 5 from 3 animals). C. Representative Western 486 
blot and quantitation of serine-40 phosphorylated TH (pTH) and -actin content in the median 487 
eminence and arcuate nucleus of control (Ctrl) and naloxone-treated (Nalo) lactating mice (10 488 
mg/kg). Data represent the mean ± SEM. (* p < 0.05, unpaired Student’s t-test, n = 4 controls, 489 
5 naloxone). Scale bars: 50 μm. 490 
 491 
Figure 6. Met-enkephalin increases Ca2+ signaling and prolactin secretion from pituitary 492 
lactotrophs of lactating mice.  A. Representative image of Fura-2 fluorescence in an acute 493 
pituitary slice from PRL-DsRed mouse. B. Example traces for the 6 lactotrophs (circled in 494 
panel A) treated for 15 min with met-enkephalin (500 nM, indicated by the bar). C. 15 min 495 
treatment with met-enkephalin induced increased Ca2+ spiking in approximately one third of 496 
the lactotrophs (n = 327/957 responsive lactotrophs in 7 slices from 3 animals). D-E. STFT 497 
analysis confirmed the presence of increased power at higher frequency ranges during the 498 
application of enkephalin (Control vs Enk p < 0.0001, Wash vs Enk p < 0.0001, analysis 499 
performed using a custom script and mixed effects model in R). F. Met-enkephalin (500 nM 500 
for 15 min) significantly increased prolactin (PRL) secretion from hemi-pituitary explants 501 
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compared to those maintained in media alone (* p < 0.05, ** p < 0.01 unpaired Student’s t-502 
test, n = 4-6 pituitaries). Open columns = saline treated, filled columns = enkephalin treated.  503 
 504 
Figure 7. Diagrammatic summary depicting the lactation-induced change in the TIDA 505 
neuron phenotype. During a non-lactating state the TIDA neurons respond to prolactin by 506 
releasing dopamine (DA; light blue arrow) into the portal blood at the median eminence 507 
(ME), which in turn inhibits prolactin secretion from lactotrophs. Chronic exposure to the 508 
prolactin agonist placental lactogen during pregnancy results in an alteration in the prolactin 509 
receptor signaling pathway which supports met-enkephalin (ENK) expression in a 510 
subpopulation the TIDA neurons. Suckling-induced activation of these neurons results in the 511 
release of the opioid which acts on neighbouring TIDA neurons to suppress dopamine 512 
synthesis (red arrows) and secretion at the median eminence (broken arrow), and directly on 513 
the lactotrophs, increasing prolactin secretion. As a result of this lactation-induced change in 514 
the TIDA neuron phenotype the original prolactin-mediated negative feedback loop has been 515 
effectively converted to one of positive feedback. 516 
 517 
STAR METHODS 518 
KEY RESOURCES (see submitted table) 519 
CONTACT FOR REAGENT AND RESOURCES SHARING 520 
Further information and requests for resources and reagents should be directed to and will be 521 
fulfilled by the Lead Contact, Stephen Bunn, (stephen.bunn@otago.ac.nz). 522 
 523 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 524 
Genetic mouse models.  525 
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Generation of PRLRlox/lox/CamK-Cre mice. A conditional transgenic mouse was also used 526 
in which prolactin receptors had been deleted from most forebrain neurons, including TIDA 527 
neurons, by crossing homozygous female prolactin receptor flox mice (PRL-Rlox/lox) with 528 
heterozygous male CamKinase II Cre-recombinase mice (Brown et al., 2016). In brief, the 529 
presence of the wild-type Prlr allele was detected by primer 1 (5’-TGT CCA GAC TAC AAA 530 
ACC AGT GGC-3’) and primer 2 (5’-CAG TGC TCT GGA GAG CTG GC-3’), which span 531 
the Lox71 site subsequent to exon 5 and amplify a 546 bp product from wild-type mice but 532 
not from Prlrlox/lox mice. Mice carrying a Prlr lox/lox allele were identified using primer 1 533 
and primer 3 (5’-ACC TCC CCC TGA ACC TGA AAC ATA A-3’). Primer 3 is located 534 
within the inverted GFP sequence and thus only produces a ~400 bp band from mice 535 
heterozygous or homozygous for the Prlr lox/lox allele, whereas no band is generated from 536 
wild-type mice. The presence or absence of CamK-Cre was determined using primers creP1 537 
(5’-GGT TCT CCG TTT GCA CTC AGG-3’), creP3 (5’-CTG CAT GCA CGG GAC AGC 538 
TCT-3’), and creP17 (5’-GCT TGC AGG TAC AGG AGG TAG T-3’). CreP1 and creP3 539 
span the start site of the endogenous CaMKII gene locus and produce a 285 bp band in wild-540 
type animals only. CreP17 anneals within the inserted cre sequence at the modified 541 
CaMKII-cre gene locus to generate a 380 bp product with creP1, but only in mice with at 542 
least one copy of this Cre construct.  543 
Generation of prolactin-DsRed mouse. Transgenic mice expressing DSRed under the 544 
control of the prolactin promoter were generated as previous described in He et al 2010 and 545 
Hodson et al 2012. 546 
 547 
Animal care and procedures.  Animal procedures complied with the animal welfare 548 
guidelines of the European Community (Agreement 34.128) or the Animal Ethics Committee 549 
of the University of Otago. Adult virgin female mice aged 8-12 weeks and weighing 20-25 g 550 
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were obtained from the University of Otago animal breeding facility, or for data presented in 551 
Figures 5, 7 and 8, from Charles River (France). Animals were group housed under controlled 552 
temperature (22 ± 1oC) and lighting (12 h light, 12 h dark cycle, lights on at 0600 h) 553 
conditions with ad libitum access to food and water. Estrous cycles were monitored by daily 554 
cytological examination of vaginal smears with diestrous animals used as non-pregnant 555 
controls. Late-pregnant mice were used on day 18 of pregnancy, the presence of vaginal plug 556 
indicating day 1, and lactating mice were used between day 7 and 10 post-partum. In some 557 
experiments, endogenous prolactin secretion was suppressed by three consecutive injections 558 
of bromocriptine mesylate (5 mg/kg sc every 12 h, Sigma-Aldrich). Some animals were 559 
injected with ovine prolactin (10 mg/kg ip, Sigma-Aldrich) at the same time as the 560 
bromocriptine treatment. For investigation of prolactin action on intracellular signaling 561 
pathways, mice were injected with saline or ovine prolactin (10 mg/kg ip) 20 min prior to 562 
being perfused and processed for immunohistochemistry (see below). Immunohistochemical 563 
staining for met-enkephalin required animals to be treated with 30 μg colchicine (Sigma-564 
Aldrich; 1 μl icv injection at Bregma +0.75 mm lateral, -0.1 mm posterior and +2.4 mm 565 
ventral) 24 h before perfusion. Serum levels of mouse prolactin were measured using 566 
radioimmunoassay as described previously (Brown et al., 2010). The effect of maintaining 567 
elevated prolactin concentrations in the absence of the suckling stimulus on Penk mRNA 568 
expression was investigated using lactating mice which were without pups for 24 h. Prolactin 569 
levels were maintained in the absence of suckling by a subcutaneous osmotic minipump 570 
(1003D, AlzetTM) delivering ovine prolactin (1500 μg/d in 0.01 M sodium bicarbonate buffer 571 
(pH 9.2); biopotency 20-50 IU, Sigma-Aldrich). Prolactin or vehicle (saline) filled pumps 572 
were implanted on days 4 to 6 of lactation under isoflurane anaesthesia and the animals left to 573 
recover for 24 h. The pups were then removed and the dams left for a further 24 h before they 574 
were perfused with 2 % PFA in 0.1 M phosphate buffer (pH 7.4). Atrial blood samples 575 
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obtained immediately prior to perfusion were used for the measurement of plasma ovine 576 
prolactin concentrations by radioimmunoassay.  577 
 578 
METHOD DETAILS 579 
 580 
Immunohistochemistry. Animals were euthanized with 3 mg sodium pentobarbital, 581 
transcardially perfused with 4% paraformaldehyde and the brains excised and post-fixed in 582 
the same fixative for at least 1 h before being cryoprotected with 30% sucrose in Tris-buffered 583 
saline (TBS) at 4oC overnight. Four sets of 30 μm sections from the level of paraventricular 584 
nucleus (Bregma -0.58 mm) to caudal arcuate nucleus (Bregma -2.12 mm) were obtained. 585 
Immunostaining for either met-enkephalin or TH was achieved by incubating tissue sections, 586 
in which endogenous peroxidase activity had been quenched (0.1% H2O2:40% methanol in 587 
TBS), overnight at 4oC with either rabbit anti-methionine enkephalin (Immunostar, catalog 588 
#20065) or rabbit anti-TH (Millipore, catalog #AB151) diluted 1:1000 and 1:10000 589 
respectively, in TBS containing 0.03% Triton-X, 0.25% bovine serum albumin and 2% 590 
normal goat serum. Sections were then incubated for 90 min at room temperature with 591 
biotinylated goat anti-rabbit IgG (Invitrogen; diluted 1:500) and staining visualized using 592 
biotin-avidin complex kit (Vector Laboratories) with nickel enhanced 3,3'-diaminobenzidine 593 
(DAB) (Sigma-Aldrich). Immunostaining for pSTAT5 required antigen retrieval (5 min in 10 594 
mM Tris-HCl, pH 10 at 90oC followed by a further 5 min cooling at room temperature) and 595 
three 10 min washings in TBS (Brown et al. 2010). Endogenous peroxidase activity was then 596 
quenched as above and sections incubated for 72 h at 4oC with rabbit anti-pSTAT5 (Tyr694) 597 
(Cell Signaling Technology catalog #9359; diluted 1:400) followed by nickel-enhanced DAB 598 
detection as above. Dual-labeling these sections for TH was achieved by repeating the 599 
peroxidase quenching and then incubating overnight at 4oC with rabbit anti-TH (diluted as 600 
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above) followed by peroxidase-conjugated goat anti-rabbit IgG (Vector Laboratories; diluted 601 
1:200) and then DAB without nickel enhancement. Dual-labeling for TH with either met-602 
enkephalin or pERK1/2 required the use of fluorescently-conjugated anti-mouse secondary 603 
antibodies. To achieve low background staining, endogenous mouse immunoglobulins were 604 
first blocked by incubating the sections overnight at 4oC with an AffiniPure Fab' fragment of 605 
goat anti-mouse IgG (H+L) (Jackson ImmunoResearch Laboratories, catalog #15-007-003; 606 
diluted 1:100 in TBS), followed by a cocktail of mouse anti-TH (Millipore, catalog 607 
#MAB318, diluted 1:1000) with anti-met-enkephalin (as above) or rabbit anti-phospho-608 
pERK1/2, (Cell Signaling Technology, catalog #4370 diluted 1:1000) overnight at 4oC. 609 
Staining was visualized using the fluorescently-tagged secondary antibodies (Molecular 610 
Probes catalog #A11029 and #A11036, both diluted 1:1000). All DAB or fluorescently 611 
stained sections were mounted on gelatin-coated glass slides and cover-slipped with DPX or 612 
Vectashield mounting medium, respectively. Stained sections were viewed and photographed 613 
using an Olympus BX51 microscope. Confocal images were captured using a Zeiss LSM 510 614 
Meta upright confocal microscope with excitation at 488 nm and 543 nm and a z-interval of 5 615 
m. A positive-labeled cell was counted if it had the nucleus present with at least one 616 
proximal process visible and was of approximately 10-20 μm in diameter. Quantification was 617 
performed from 3-4 representative sections of dorsomedial arcuate nucleus, an anatomical 618 
location of the TIDA population (Lyons et al., 2010; Zhang and van den Pol, 2015). In Figure 619 
1, the whole arcuate nucleus was analyzed to provide a more appropriate comparison to the 620 
qPCR data obtained from tissue punches. 621 
 622 
Western blotting. For the data in Figure 5 mice injected (ip) with naloxone (10 mg/kg) or 623 
saline (day 10 of lactation) were killed by cervical dislocation and the brains immediately 624 
excised and frozen on dry ice before being stored at -80oC. Coronal sections (300 μm at 625 
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approximately Bregma -1.46 to -2.12 mm) were cut on a cryostat and micropunched samples 626 
of the arcuate nucleus, prepared as described above but including the median eminence, were 627 
transferred to 30 μl of 50 mM Tris buffer containing 2 mM ethylenediaminetetraacetic acid, 628 
10 mM NaF, 2 mM NaP2O7, 2 mM Na2-glycerophosphate, 1 mM Na3VO4, 1 mM PMSF and 629 
4% sodium lauryl sulphate. Protein concentrations were determined using a Pierce BCA kit. 630 
β-mercaptoethanol (8% final) was then added to the samples, which were heated to 100oC. 631 
Protein samples (10 μg) were separated by 7.5% sodium dodecyl sulphate-polyacrylamide gel 632 
electrophoresis and transferred to nitrocellulose membranes which were probed with 633 
antibodies against TH phosphorylated at Ser-40 (Zymed Laboratories, catalog #368600) 634 
diluted 1:2000 in TBS containing 0.3% Triton-X (Romano et al., 2013). β-actin labeling was 635 
used as a loading control (Abcam, catalog #ab8226, diluted 1:12000). For the data presented 636 
in Figure S2 animals were treated with bromocriptine mesylate (5mg/kg) followed by 20 min 637 
of ovine prolactin (10 mg/ kg). For detection of phospho-proteins, antibodies against anti-638 
pSTAT5 (Tyr694) (Cell Signaling Technology catalog #9359; diluted 1:1000) and anti-639 
pERK1/2 (Cell Signaling Technology catalog #4370; diluted 1:12000) both diluted in TBST 640 
containing 5% BSA were used. The respective non-phospho proteins were detected with anti- 641 
STAT5a/b pan (R&D System catalog AF2168; diluted 1:1000) and anti-p44/42 MAPK (Cell 642 
Signaling Technology catalog #4695; diluted 1:6000) diluted in 5% non-fat milk in TBST and 643 
were used to normalize the levels of phospho-proteins. Immunoreactive bands were visualized 644 
using enhanced chemiluminescence detection in accordance with the manufacturer's 645 
instructions and densitometric analysis performed using Quantity One 1-D Analysis Software 646 
(Bio-Rad).  647 
 648 
Quantitative PCR. Quantitative PCR was used to determine the level of mRNA expression 649 
in tissue samples micropunched from the arcuate nucleus. Mice were decapitated and their 650 
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brains removed, frozen on dry-ice and stored at -80oC. Under RNase-free conditions, 300 μm 651 
coronal cryostat sections were prepared at approximately Bregma -1.34 to -2.30 mm and 652 
tissue punches collected from the arcuate nucleus using a blunt-end needle. A single 500 μm 653 
diameter punch was obtained from each section centered on the midline immediately superior 654 
to the median eminence. Punches from three consecutive sections were pooled in 350 μl of 655 
lysis buffer (RNeasy Mini Kit, Qiagen) containing 1% β-mercaptoethanol. Following 656 
sonication, RNA was extracted using RNeasy mini spin columns (Qiagen) and purity 657 
determined using a Nanodrop 2000 spectrophotometer (Life Technologies). All samples used 658 
in this study had a 260/280 nm ratio of 2 or greater. RNA aliquots (35 ng) were reverse 659 
transcribed using SuperScript III reverse transcriptase (Invitrogen) and stored at -20oC until 660 
required. Oligonucleotide primers for the following transcripts were designed using 661 
ensemble.org and Primer Blast. Penk (NM_001002927.2) forward: 5'-TCC TGA GGC TTT 662 
GCA CCT GG-3', reverse: 5’-AGT GTG CAG CCA GGA AAT TG-3’); Th (NM_009377.1): 663 
forward: 5’-GCC CCC AGA GAT GCA AGT C-3’ and reverse: 5’-TGT TGG CTG ACC GCA 664 
CAT-3’ and β-actin (NM_007393.3), forward: 5'-ATG GGG CCA GGA GAA ATC TA-3' and 665 
reverse: 5'-GCC TGG ATG GCT ACG TAC ATC ATG-3' were used. SYBR green based 666 
qPCR was performed in triplicate using an Applied Biosystems ViiA7 qPCR system (Life 667 
Technologies) and the fold changes in mRNA levels determined by normalizing against β-668 
actin mRNA using the ΔΔCt method. Primer efficiencies were confirmed to lie between 92 669 
and 105%. 670 
 671 
In situ hybridization for Penk mRNA. Animals were decapitated and coronal sections of 16 672 
μm were obtained using a cryostat at -20oC and immediately mounted onto RNase free 673 
aminopropyltriethoxysilane (APS)-coated microscope slides. Slides mounted with brain 674 
sections were thawed at 55°C for 5 min before sections were fixed in 2 % PFA (5 min). The 675 
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slides were washed in 0.5  sodium chloride citrate buffer (SCC; 75 mM sodium chloride, 7.5 676 
mM sodium citrate, pH 7) prior to incubation in proteinase K (2 µg/ml and acetylation with 677 
0.25 % acetic anhydride). The slides were washed in 2  SCC before being taken through 678 
graded ethanol incubations of increasing concentration before incubation in chloroform for 5 679 
min. Slides were air-dried for 3 h. Primers were designed for the mouse Penk gene using the 680 
Genbank mRNA sequence (accession number NM 001002927.2). The sequences were:5’-681 
CTTTGCACCTGGCTGCTGGC-3’(forward) and 5’-GGGAACTCGGGCCTGGACAC-3’ 682 
(reverse). Reverse transcription polymerase chain reaction (PCR) was used to generate a DNA 683 
template with sequences encoding the T7 and SP6 polymerase promoter sites incorporated 684 
onto the ends of the primer sequences. 35S UTP-labelled RNA probes were transcribed from 685 
the cDNA template using a Riboprobe® in vitro transcription kit (Promega) and the 686 
appropriate polymerase (T7 for the antisense probe, SP6 for the sense probe). The probes 687 
were purified using Mini Quick spin columns (Roche) to remove unincorporated nucleotides. 688 
Probes were denatured at 95º C for 3 min (40 ng probe/slide with 50 µg tRNA/slide). Sections 689 
were then covered with 100 µl hybridisation buffer/probe mix (hybridisation buffer: 100 mM 690 
dithiothreitol, 0.3 M sodium chloride, 20 mM Tris base (pH 8), 5 mM EDTA, 1  Denhardt's 691 
solution, 10 % dextran sulfate, 50 % formamide). The slides were coverslipped and incubated 692 
overnight at 55º C. Sections were washed, incubated with ribonuclease A (20 µg/ml) for 30 693 
min and then washed in 0.1  SCC (with 10 mM β-mercaptoethanol and 1 mM EDTA) at 55º 694 
C for 2 h. Sections were incubated with anti-digoxigenin (DIG) antibody conjugated to 695 
alkaline phosphatase (1:2000) for 48 h. The DIG-labelled probes were detected by NBT/BCIP 696 
(nitroblue tetrazolium chloride/5-bromo-4 chloro-3-indolyl-phosphate) substrate. Colour 697 
development was monitored under the microscope. The reaction was terminated after 23 h by 698 
four 30 min washes in buffer (150 mM NaCl, 10 mM NaH2PO4, 1 mM EDTA). Sections 699 
were dipped in ethanol, dried at 42º C for 1 h, immersed in xylene and coverslipped with 700 
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Vectamount mounting medium. No staining was evident in sections incubated with the sense 701 
probe. Images were captured using an Olympus BX61 light microscope fitted with a 702 
QImaging Micropublisher 5.0RTV camera (QImaging, Surrey, Canada). Quantification and 703 
analysis were performed as described previously (Gustafson et al., 2017) 704 
 705 
In vitro measurement of met-enkephalin and TH expression in the median eminence. 706 
Lactating mice (day 10 of lactation) were killed by rapid decapitation, following isoflurane 707 
anesthesia. The brain was quickly removed and placed in ice-cold artificial cerebrospinal fluid 708 
(aCSF) containing 118 mM NaCl, 3 mM KCl, 11 mM D-glucose, 10 mM HEPES, 25 mM 709 
NaHCO3, 6 mM MgCl2 and 0.5 mM CaCl2, osmolarity between 295 and 305 mOsm, pH 7.2 710 
when gassed with 5% CO2 and 95% O2. The brain was then glued to the stage of a vibratome 711 
and 150 μm thick coronal sections cut and incubated in aCSF for 60 min at 37° in 5% 712 
CO2/95% O2. The medium was then replaced with another 500 μl of aCSF with or without 713 
ovine prolactin (500 ng/ml) and incubated for a further 30 min and then the tissue immersion 714 
fixed in 4% paraformaldehyde overnight. The next day, immunohistochemical detection of 715 
met-enkephalin and TH was performed, as described above. Slices were imaged on a Zeiss 716 
LSM 510 Meta confocal microscope and densitometric analysis performed using ImageJ. 717 
 718 
Two-photon multicellular Ca2+ imaging in the pituitary. Ca2+ imaging was performed on 719 
pituitary slices from lactating mice (day 10) expressing DsRed under the control of the 720 
prolactin promoter as described previously (Hodson et al., 2012). Briefly, pituitaries were 721 
embedded in low melting point agarose (Invitrogen), before preparing slices (150 µm) using a 722 
vibrating microtome (Campden Instruments). Slices were then loaded for 1 h with 20 µM 723 
Fura-2 LR (TEFLabs) supplemented with pluronic acid (0.005%; Invitrogen). Multicellular 724 
Ca2+ imaging was performed using a TriM Scope (LaVision BioTec) coupled to an Olympus 725 
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BX51 frame, 20x 0.95 NA water-dipping objective (Olympus) and femtosecond-pulsed near-726 
infrared laser (Coherent Chameleon) to produce two-photon excitation at λ = 780 nm (Fura-2) 727 
and λ = 970 nm (DsRed). Emitted signals were detected at λ = 525 ± 50 nm (Fura-2) and λ = 728 
593 ± 40 nm (DsRed) using a 14-bit, 512×512 pixel back-illuminated EM-CCD camera 729 
(Andor). Slices were perfused at 36 °C in a buffer containing 125 mM NaCl, 2.5 mM KCl, 730 
1.25 mM NaH2PO4, 26 mM, NaHCO3, 12 mM glucose, 2 mM CaCl2 and 1 mM MgCl2 with 731 
met-enkephalin (500 nM) added at the indicated time.  A region of interest (ROI) was used to 732 
extract the intensity-over-time from Fura-2 loaded DsRed-positive cells (i.e. lactotrophs). 733 
Cells were manually triaged and only those responding to treatment considered for further 734 
analysis (33.9 ± 2.3%; 327/957 cells analyzed from 7 slices). Ca2+-spiking frequency was 735 
measured in the responsive subpopulation using the Short-Time Fourier Transform and 736 
component frequencies plotted as a function of their power for each independent recording 737 
using 0.005 Hz bins to produce a power spectrum. Significance was determined for the 738 
frequency with the greatest power before, during and after treatment. All analysis was 739 
performed using custom scripts in R (R-Project) and results considered significant at P<0.05. 740 
 741 
QUANTITATION AND STATISTICAL ANALYSIS. 742 
All experiments were conducted on female mice. Unless otherwise stated, statistical analysis 743 
was performed using PRISM software (GraphPad). Individual tests and n values are reported 744 
in the Results and in the relevant figure legends. All data are presented as mean ± SEM per 745 
section. In all statistical tests, a value of P < 0.05 was accepted as significant. The number of 746 
TH and met-enkephalin immunoreactive cells in diestrus, late pregnant and lactating mice in 747 
Figure 1 was compared by one-way ANOVA followed by a Tukey’s multiple comparison test 748 
with 4 to 5 animals per group. A one-way ANOVA was similarly used to compare levels of Th 749 
mRNA and Penk mRNA expression between these three groups. In Figure 1 the level co-750 
 32 1
 
expression of TH and met-enkephalin expression during diestrus and lactation were compared 751 
using an unpaired Student’s t-test with 3 to 4 animals per group. In Figure 2 the effect of 752 
altering prolactin levels on the number of cells expressing met-enkephalin was compared 753 
using one-way ANOVA followed by a Tukey’s multiple comparison test with 5 to 8 animals 754 
per group. The number of Penk mRNA positive neurons between diestrous and lactating 755 
groups (Figure 2) was compared using unpaired Student’s t-test with 4 to 6 animals per group. 756 
The effect of prolactin after pup withdrawal on the number of Penk mRNA expressing cells 757 
was compared using unpaired Student’s t-test with 4 to 6 animals per group. In Figure 3 the 758 
effect of prolactin receptor deletion on the number of cells expressing met-enkephalin (3 759 
animals per group) and the number of Penk mRNA positive cells (5 to 6 animals per group) 760 
was compared using two-way ANOVA followed by a Tukey's multiple comparison test with 3 761 
animals per group. A two-way ANOVA, followed by a Tukey's multiple comparison test, was 762 
also used to compared the number of TH immunoreactive cells expressing pSTAT5 or 763 
pERK1/2, (Figure 4) with 3 to 6 animals per group. In Figure 5 an unpaired Student’s t-test 764 
was used to compare the relative level of met-enkephalin immunoreactivity in the median 765 
eminence and the relative levels of phosphorylated TH measure by Western blot. The data 766 
obtained from Ca2+ imaging in Figure 6 was analyzed using custom scripts in R (R-Project).  767 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit polyclonal anti-methionine-enkephalin  ImmunoStar Cat#20065; 
RRID:AB_572250 
Rabbit polyclonal anti-tyrosine hydroxylase Millipore Cat#AB151; 
RRID:AB_10000323 
Mouse monoclonal anti-tyrosine hydroxylase Millipore Cat# MAB318, 
RRID:AB_2201528 
Rabbit monoclonal anti-phospho-Stat5 (Tyr694) 
(C11C5) 
Cell Signaling 
Technology 
Cat#9359; 
RRID:AB_823649 
Rabbit polyclonal anti-human/mouse STAT5a/b pan 
specific affinity purified PAb 
R & D Systems Cat# AF2168, 
RRID:AB_355174 
Rabbit monoclonal anti-phospho-p44/42 MAPK (Erk1/2) 
(Thr202/Tyr204) 
Cell Signaling 
Technology 
Cat# 4370, 
RRID:AB_2315112 
Rabbit monoclonal anti-p44/42 MAPK (Erk1/2) (137F5) Cell Signaling 
Technology 
Cat# 4695, 
RRID:AB_390779 
Rabbit polyclonal anti-phospho-tyrosine hydroxylase 
(Ser40) 
Thermo Fisher 
Scientific (Zymed) 
Cat# 36-8600, 
RRID:AB_138590 
Mouse monoclonal anti-beta actin (clone mAbcam) Abcam Cat#ab8226, 
RRID:AB_306371 
Rabbit anti-oPRL-2 NIDDK Cat#AFP-C358106 
Rabbit-mPRL NIDDK Cat#AFP-C131078 
Goat polyclonal anti-mouse IgG (H+L) (AffiniPure Fab 
Fragment) 
Jackson 
ImmunoResearch Lab 
Cat# 115-007-003; 
RRID:AB_2338476 
Goat polyclonal anti-rabbit BiotinX IgG (H+L) (Biotin-XX 
conjugated) 
Thermo Fisher 
Scientific  
Cat# B2770, 
RRID:AB_10375717 
Goat anti-mouse IgG (H+L) (Alexa Fluor 488 
conjugated) 
Molecular Probes Cat# A-11029, 
RRID:AB_138404 
Goat anti-rabbit IgG (H+L) (Alexa Fluor 568 conjugated) Molecular Probes Cat# A-11036, 
RRID:AB_143011 
Sheep anti-digoxigenin (alkaline phosphatase 
conjugated) 
Roche Cat# 11093274910 
RRID: AB_514497 
Chemicals, Peptides, and Recombinant Proteins 
Bromocriptine mesylate  Tocris Bioscience Cat#0427; CAS: 
22260-51-1 
Ovine prolactin from sheep pituitary Sigma-Aldrich L6520-250IU; CAS: 
9002-62-4 
Colchicine Sigma-Aldrich C9754-100MG; 
CAS: 64-86-8 
Ovine PRL-1-3 NIDDK Cat#AFP-10789D 
Mouse PRL NIDDK Cat#AFP-9038E 
Fura-2 LR TEFlabs No longer available 
Methionine-enkephalin Sigma-Aldrich M6638; CAS: 82362-
17-2 
Critical Commercial Assays 
RNeasy Mini Kit  Qiagen Cat#74104 
Riboprobe in vitro transcription kit Promega Cat#P1460 
SuperScript III reverse transcriptase Invitrogen Cat#180800-51 
Pierce BCA Protein Assay Kit Thermo Scientific  Cat#23227 
Key Resource Table
 Experimental Models: Organisms/Strains 
Mouse: PRLRlox/lox/CamK-Cre Brown et al., 2016 N/A 
Mouse: PRL-DsRed   He et al. 2010 N/A 
Oligonucleotides 
Primers for Penk, forward: 
TCCTGAGGCTTTGCACCTGG, reverse 
AGTGTGCAGCCAGGAAATTG-3 (qPCR); forward: 
CTTTGCACCTGGCTGCTGGC, reverse: 
GGGAACTCGGGCCTGGACAC (ISH) 
This paper NM_001002927.2 
Primers for TH, forward: GCCCCCAGAGATGCAAGTC, 
reverse: GCCTGGATGGCTACGTACATCATG 
This paper NM_009377.1 
Primers for beta-actin, forward: 
ATGGGGCCAGGAGAAATCTA, reverse: 
GCCTGGATGGCTACGTACATCATG 
This paper NM_007393.3 
   
   
Software and Algorithms 
R-projects, custom scripts This paper https://www.r-
project.org/ 
PRISM Version 7.0 GraphPad Software 
Inc. San Diego, USA 
https://www.graphpa
d.com/ 
AssayZap Version 3.0 Biosoft Cambridge, 
UK 
http://www.biosoft.co
m/w/assayzap.htm 
Image J Gustafson et al., 2017 https://imagej.nih.go
v/ij/ 
Quantity One 1-D Analysis Bio-Rad http://www.bio-
rad.com 
Other 
Micro-osmotic pump Model 1003D Alzet; Durect 
Corporation 
Cat#0000289 
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